Back to the feed
Disclosure detail

Kuros Biosciences AG

12.12.2025 · T1PCC00044

In brief

On 12.12.2025, a person holding the function "Executive member of the board of directors / senior management" at Kuros Biosciences AG disclosed a sale worth CHF 906’000 to SIX Exchange Regulation.

By amount, this ranks #8 of 17 management sales disclosed at Kuros Biosciences AG over the previous 12 months.

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Disclosure detail

A executive member of the board of directors / senior management of Kuros Biosciences AG declared a "Sale" transaction on 12.12.2025.

SIX publishes the manager's function, never their name: no individual is named in management transactions.

Transaction date12.12.2025
Issuing companyKuros Biosciences AG
ISINCH0325814116
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity30’000
Unit priceCHF 30.20
AmountCHF 906’000
ExchangeXSWX
Notification IDT1PCC00044

Other Kuros Biosciences AG insider transactions

These figures aggregate public disclosures. They are not investment advice.